- Investing Ideas
- /
- Japanese Biotech Stocks
Japanese Biotech Stocks
Results
51
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
51 companies
Kohjin Bio
Market Cap: JP¥8.2b
Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.
177A
JP¥1,597.00
7D
2.6%
1Y
-12.6%
Noile-Immune Biotech
Market Cap: JP¥8.0b
Researches and develops CAR-T cells for cancer immunotherapies.
4893
JP¥185.00
7D
-2.6%
1Y
-3.1%
Linical
Market Cap: JP¥7.9b
Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.
2183
JP¥349.00
7D
1.2%
1Y
-12.5%
TMS
Market Cap: JP¥7.1b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥159.00
7D
1.3%
1Y
-19.3%
WDB coco
Market Cap: JP¥6.5b
Provides contract services to pharmaceutical companies in Japan.
7079
JP¥2,705.00
7D
0.2%
1Y
-27.1%
Modalis Therapeutics
Market Cap: JP¥6.2b
Engages in the research and development of therapeutics to treat patients with serious genetic disorders.
4883
JP¥81.00
7D
1.3%
1Y
-13.8%
Nippon Chemiphar
Market Cap: JP¥6.0b
Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.
4539
JP¥1,672.00
7D
3.9%
1Y
3.2%
Precision System Science
Market Cap: JP¥5.7b
Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.
7707
JP¥208.00
7D
-2.8%
1Y
-26.5%
Cyfuse Biomedical K.K
Market Cap: JP¥4.9b
Engages in the development, manufacture, and sale of regenerative medicine products in Japan.
4892
JP¥591.00
7D
0%
1Y
-2.0%
Immuno-Biological Laboratories
Market Cap: JP¥4.4b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥475.00
7D
1.1%
1Y
7.0%
FunPep
Market Cap: JP¥4.3b
Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.
4881
JP¥106.00
7D
-4.5%
1Y
-22.6%
Human Metabolome Technologies
Market Cap: JP¥4.2b
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.
6090
JP¥739.00
7D
2.8%
1Y
20.6%
Ribomic
Market Cap: JP¥4.2b
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.
4591
JP¥94.00
7D
-2.1%
1Y
13.3%
Transgenic Group
Market Cap: JP¥3.7b
Develops, distributes, and licenses genetically modified animals and antibodies in Japan.
2342
JP¥220.00
7D
2.3%
1Y
-10.2%
PhoenixBio
Market Cap: JP¥1.7b
Provides contract study services for drug discovery and development primarily in Japan.
6190
JP¥417.00
7D
-1.7%
1Y
-5.2%